Chronic inflammatory bowel diseases characterized by unclear etiology, and chronic, recurrent inflammatory processes.
The differerentiation of these bowel diseases from other diseases of the digestive tract, as well as the differential diagnosis of Crohn’s disease and ulcerative colitis remain a clinical challenge.
Autoantibodies of the exocrine pancrease (PAB) have been identified as a specific serological marker for Crohn’s disease.
Glycoprotein 2 (GP2), a membrane-bound protein of the pancreas, could be identified as the major target antigen of these antibodies. Together with other circulating autoantibodies (ASCA, aANCA), PABs against GP2 can be employed for the differential diagnosis of Crohn’s disease and ulcerative colitis.
- The only commercially available ELISA with purified recombinant GP2
- Serum anti-GP2 enables differential diagnosis of Crohn’s disease and ulcerative colitis
- Anti-GP2 allows a differential diagnosis to rule out toxic, acute and infectious intestinal diseases.
Anti-GP2 is an enzyme immunoassay for the quantitive determination of IgA or IgA antibodies against glycoprotein 2 in human serum, for the diagnosis of Crohn’s disease. The diagnostic sensitivity is 27.8 % (IgG) and 13.9 % (IgA). The diagnostic specificity is 96.7 % (IgG) and 100 % (IgA). The values of intra- and interassay precision for both tests are in the range of 2 - 8 % (coefficient of variation).
|Assay Principle||Enzyme immunoassay, ELISA|
|Assay Size||96 determinations|
|Indiction||Chronic inflammatory bowel disease|
|Parameter||IgG / IgA antibodies against GP2|
|Preparation||Dilution of patient samples 1:100 with sample diluent, standards and controls are ready for use|
|Results||quantitative: Cut off: 15 U/ml (IgG); 10 U/ml (IgA)|
|Incbation Times||60 min RT - 30 min RT - 15 min RT in the dark|
|Substrate||Tetramethylbenzidine (TMB), 450 nm|
|Sample Material||Human Serum|
Roggenbuck, D., Hausdorf, G., Martinez-Gamboa, L., Reinhold, D., Büttner, T., Jungblut, P.R., Porstmann, T., Laass, M.W., Henker, J., Büning, C., Feist, E, Conrad, K. Identification of GP2, the major zymogen granulemembrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn´s disease. Gut 2009; 58: 1620-8.
Zhang, S., Wu, Z., Luo, J., Ding, X., Hu, C., Li, P., Deng, C., Zhang, F., Qian, J., Li, Y. Diagnostic Potential of Zymogen Granule Glycoprotein 2 Antibodies as Serological Biomarkers in Chinese Patients with Crohns Disease. Medicine 2015 Oct.; 94 (42): p e1654.